£1.08m
−8%vs Dec 2023ActiveSC575642Private limited companyClydebank
BIOCLAVIS LIMITED
Significant control: Joel Mccomb (75–100%)
From public filings as at 31 Aug 2026; may contain errors or be out of date. Verify at Companies House · Terms
Watch this company
Get an email when Companies House records a change for Bioclavis Limited: status, filings, accounts, officers or owners. Free.
Not live yet: alerts start by 15 December 2026. We store your email and this company number only, for these alerts. If alerts don’t launch, we tell you and delete your address. Privacy
Coming soon · product and service lists
What does Bioclavis Limited sell?
Registered activity: Research and experimental development on biotechnology (SIC 72110). We’re building product and service lists for UK companies. Get this one when it’s ready.
One email, only about this. If we don’t launch within 60 days we’ll tell you. Privacy
01
Summary
BIOCLAVIS LIMITED is an active private limited company (company number SC575642) incorporated on 6 September 2017, registered in Clydebank. Its registered activity is research and experimental development on biotechnology (SIC 72110). Latest small accounts cover the period ending 31 December 2024, showing net assets of £1.08m and cash of £685k, with 11 employees on average. Net assets fell 8% on the prior period (£1.17m).
Peer position · net assets
By net assets it sits in the top quarter of 2,418 comparable companies in the UK (median £1,000, upper quartile £92k).
02
Ownership and control
- Mr Joel Mccomb
- owns 75–100% of shares
- holds 75–100% of voting rights
- can appoint or remove directors
Persons with significant control hold 25% or more of shares or voting rights. Smaller shareholdings are only listed in confirmation-statement documents. Directors and secretaries: see the officers list at Companies House.
03
Key dates
- Incorporated
- 6 September 20179 yrs ago
- Next accounts due
- 30 September 202624 days overdue
- Confirmation statement due
- 20 September 2027in 331 days
Due dates are expected from Companies House filing rules; confirm on the official register before relying on them.
04
Activity
- SIC 72110
- Research and experimental development on biotechnology
- Accounts type
- Total Exemption Full
- Size band
- SmallCompanies Act thresholds
05
Financials
£685k
−2%vs Dec 2023Not reported
11
−15%vs Dec 2023| Period end | Net assets | Cash | Debtors | Creditors <1y | Turnover | Profit | Employees |
|---|---|---|---|---|---|---|---|
| 31 December 2024 | £1.08m | £685k | — | — | — | — | 11 |
| 31 December 2023 | £1.17m | £697k | — | — | — | — | 13 |
Cash per employee£62kCash ÷ average employees
Figures as filed in iXBRL accounts at Companies House. "—" means the line was not reported in that filing.
06
Filing and accounts signals
- Net assets above zeroNet assets £1,075,408 at 31 December 2024
- Cash at bank of £50,000 or moreCash £685,216
- Incorporated five or more years agoIncorporated 6 September 2017
- Accounts past their due dateDue 30 September 2026
Neutral facts read from the register and filed accounts, each with its evidence. They are not a rating, a prediction or advice, and may be incomplete or out of date. How each signal is derived.
07
Timeline
- Confirmation statement duein 331 days
- Next accounts due24 days overdue
- Accounts period endNet assets £1.08m · small accounts
- Accounts period endNet assets £1.17m · small accounts
- Incorporated
08
Similar companies in Glasgow
- SUCCURRO CLINICAL RESEARCH LIMITEDGlasgow · inc. Oct 2017
- PPG (GLASGOW) LIMITEDGlasgow · inc. Dec 2017
- QA QUALITY SOLUTIONS LIMITEDLanark · inc. Dec 2017
- ENTEROBIOTIX LIMITEDBellshill · inc. Mar 2017
- FOYS LTDGlasgow · inc. Apr 2018
- PROMETHEUS REGENERATION R&D LIMITEDGlasgow · inc. May 2018
All companies incorporated on 6 September 2017 · in Sept 2017.
09
Reminders for BIOCLAVIS LIMITED
Get an email before each filing deadline — accounts and confirmation statement — so nothing is late.